ZANZALINTINIB

Clinical trials for ZANZALINTINIB explained in plain language.

Never miss a new study

Get alerted when new ZANZALINTINIB trials appear

Sign up with your email to follow new studies for ZANZALINTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug duo aims to halt rare, aggressive cancers

Disease control Not yet recruiting

This study aims to see if a combination of two drugs, zanzalintinib and pembrolizumab, can help control the growth of certain advanced or spreading soft-tissue sarcomas. It will enroll about 20 adults with specific sarcoma subtypes who have not had certain prior treatments. The m…

Matched conditions: ZANZALINTINIB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

ZANZALINTINIB

Get alerted when new ZANZALINTINIB trials appear

New drug duo aims to halt rare, aggressive cancers